Peters, Bjoern
- La Jolla Institute for Immunology (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,680
- Program Leader
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#3,680
By linked amount among FY2023 PIs
Earliest Year Loaded
2011
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Peters, Bjoern as a PI. Multi-PI records show the full award amount for context.
- 5U24CA248138-03U24Contact PITHE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE$839.9Kaward amount
- 5U01AI141995-05U01Contact PIIdentifying mechanisms and correlates of long-lasting vaccine-induced immunity to whooping cough$823.2Kaward amount
- 3U24CA248138-03S1U24Contact PITHE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE$366Kaward amount
Award organization
Organizations that administered FY2023 awards listing Peters, Bjoern as a PI.
FY2023 award administered by La Jolla Institute for Immunology (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardLa Jolla Institute for Immunology
- 2011$500K Cumulative Funding
- 2011$1M Cumulative Funding
- 2011Entered Top 50% NationallyRanked #6068
- 2012$2M Cumulative Funding
- 2015$5M Cumulative Funding
- 2018Program/Center Grant Leader
- 2020Entered Top 25% NationallyRanked #4072
- 2022$10M Cumulative Funding